bullish
China Blood Products: Deals Highlight Values
566 Views19 Mar 2019 03:30
Grifols SA (GRF SM) and Shanghai RAAS Blood Products Co Ltd (002252.SZ) recently announced an asset exchange that effectively combines the...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
Kemp Dolliver, CFA
Founder
Price Chart(Sign Up to Access)
- CBPO's Vote Gets Up But Dissenters Lurk02 Mar 2021
- China Biologics (CBPO US): Firm Offer Backed By Prerequisite Votes20 Nov 2020
- Vital Fluids: Proposal Rejuvenates China Biologics19 Sep 2019
- China Blood Products: Deals Highlight Values19 Mar 2019
- China ADR Privatizations: The Challenges of Getting the Best Deal01 Jul 2015
x